Novo Nordisk weight-loss drug wins US approval as a daily pill ⊕
found
a story from Financial Times ✅ › Financial Times
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Danish company will be first to market with oral obesity treatment but rival Eli Lilly is not far behind